Robert J. Gould
2022 - Fulcrum Therapeutics
In 2022, Robert J. Gould earned a total compensation of $118.3K as Former Interim President and Chief Executive Officer at Fulcrum Therapeutics.
Compensation breakdown
| Option Awards | $73,342 |
|---|---|
| Other | $45,000 |
| Total | $118,342 |
Gould received $73.3K in option awards, accounting for 62% of the total pay in 2022.
Gould also received $45K in other compensation.
Rankings
In 2022, Robert J. Gould's compensation ranked 5,556th out of 5,732 executives tracked by ExecPay. In other words, Gould earned more than 3.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,556 out of 5,732 | 3rd |
Division Manufacturing | 3,035 out of 3,121 | 3rd |
Major group Chemicals And Allied Products | 1,384 out of 1,416 | 2nd |
Industry group Drugs | 1,291 out of 1,317 | 2nd |
Industry Pharmaceutical Preparations | 941 out of 963 | 2nd |
Source: SEC filing on April 19, 2024.
Gould's colleagues
We found two more compensation records of executives who worked with Robert J. Gould at Fulcrum Therapeutics in 2022.